< Back to companies
OncoGenomX

OncoGenomX

Allschwil, Switzerland

OncoGenomX is an ai-decision support solution (aiDSS) company known for its revolutionary approach to individualized drug-tumor matching, with the mission to end under- and overtreatment of patients, avoid expenditures for ineffective treatments, minimizing the risk of therapy failure and liability.

Only accessible to MedStartr community members. Join now

Company Info

Founded
2019
Website
oncogenomx.ch/
Only accessible to MedStartr community members. Join now

What do you think of OncoGenomX?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Innovation

Clinical Benefit

Feasibility

Scalability

Only accessible to MedStartr community members. Join now